[{"address1": "65 Yigal Alon Street", "city": "Tel Aviv", "zip": "6745442", "country": "Israel", "phone": "972 3 717 7050", "website": "https://www.painreform.com", "industry": "Drug Manufacturers - Specialty & Generic", "industryKey": "drug-manufacturers-specialty-generic", "industryDisp": "Drug Manufacturers - Specialty & Generic", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "PainReform Ltd., a clinical stage specialty pharmaceutical company, engages in the development of therapeutics that provides an extended period of post-surgical pain relief in Israel. The company engages in developing PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia. It is currently conducting Phase 3 clinical trials of PRF-110 for the treatment of patients undergoing bunionectomy surgery and hernia repair. The company was incorporated in 2007 and is based in Tel Aviv, Israel.", "fullTimeEmployees": 6, "companyOfficers": [{"maxAge": 1, "name": "Dr. Ehud  Geller Ph.D.", "title": "Executive Chairman", "fiscalYear": 2022, "totalPay": 150000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Ilan  Hadar M.B.A.", "age": 54, "title": "CEO & CFO", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": 457000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Sigal  Aviel", "age": 59, "title": "Chief Operating Officer", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": 329000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Prof. Eli  Hazum Ph.D.", "title": "CTO & Director", "fiscalYear": 2022, "totalPay": 144000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rita  Keynan", "age": 54, "title": "Vice President of Pharmaceutical Operations", "yearBorn": 1969, "fiscalYear": 2022, "totalPay": 315000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen A. Cooper D.M.D Ph.D.", "title": "Executive Vice President of Development", "fiscalYear": 2022, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1672444800, "maxAge": 86400, "priceHint": 4, "previousClose": 2.17, "open": 2.2542, "dayLow": 2.0657, "dayHigh": 2.2542, "regularMarketPreviousClose": 2.17, "regularMarketOpen": 2.2542, "regularMarketDayLow": 2.0657, "regularMarketDayHigh": 2.2542, "beta": 0.546, "forwardPE": -0.5110565, "volume": 20358, "regularMarketVolume": 20358, "averageVolume": 27603, "averageVolume10days": 20730, "averageDailyVolume10Day": 20730, "bidSize": 4000, "askSize": 1800, "marketCap": 4214579, "fiftyTwoWeekLow": 0.417, "fiftyTwoWeekHigh": 26.41, "fiftyDayAverage": 2.4479, "twoHundredDayAverage": 2.91976, "currency": "USD", "enterpriseValue": -5244638, "floatShares": 1301687, "sharesOutstanding": 2026240, "sharesShort": 8421, "sharesShortPriorMonth": 6037, "sharesShortPreviousMonthDate": 1701302400, "dateShortInterest": 1703808000, "sharesPercentSharesOut": 0.0054, "heldPercentInsiders": 0.05473, "heldPercentInstitutions": 0.21479, "shortRatio": 0.27, "shortPercentOfFloat": 0.0069, "impliedSharesOutstanding": 2026240, "bookValue": 5.545, "priceToBook": 0.37511268, "lastFiscalYearEnd": 1672444800, "nextFiscalYearEnd": 1703980800, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -7619000, "trailingEps": -6.64, "forwardEps": -4.07, "lastSplitFactor": "1:10", "lastSplitDate": 1688342400, "enterpriseToEbitda": 0.566, "52WeekChange": 3.9911113, "SandP52WeekChange": 0.20484698, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "PRFX", "underlyingSymbol": "PRFX", "shortName": "PainReform Ltd.", "longName": "PainReform Ltd.", "firstTradeDateEpochUtc": 1598967000, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "cdbb035d-94d1-3758-931b-64e3020464de", "messageBoardId": "finmb_54214693", "gmtOffSetMilliseconds": -18000000, "currentPrice": 2.08, "targetHighPrice": 11.0, "targetLowPrice": 11.0, "targetMeanPrice": 11.0, "targetMedianPrice": 11.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 8580000, "totalCashPerShare": 5.506, "ebitda": -9261000, "totalDebt": 94000, "quickRatio": 7.836, "currentRatio": 9.809, "debtToEquity": 1.088, "returnOnAssets": -0.45048, "returnOnEquity": -0.69078004, "freeCashflow": -4867500, "operatingCashflow": -7995000, "financialCurrency": "USD", "trailingPegRatio": null}]